US researchers are honing in on the development of what may be the first non-steroidal, oral contraceptive for men. Low doses of a compound that interferes with retinoic acid receptors (RARs) stopped sperm production in male mice with no apparent side effects. And crucial for a contraceptive, normal fertility was restored soon after drug administration was terminated.
Read more at Columbia University Medical Center